What Know About This Mineralys Insider Sale Before FDA Date
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
Wealth Planning Strategies For Families
Wealth planning is crucial for families. Explore tailored strategies that can help secure your family's financial future.
16,354 articlesActive Funds Can’t Beat the S&P 500? One Fund Proves It
A newly launched active ETF has delivered stronger net returns than the S&P 500 after costs over the latest 12-month ...
This $38.8 Million Vicor Bet Sparks a 200% Surge
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
Intuitive Machines Stock Soaring: What’s Behind the Rally
Intuitive Machines has sparked a sharp turn in its stock without a major news release. This article breaks down why i...
Centralized Exchanges Despite Collapse Stand Firm in 2026
Bitcoin reserves on centralized venues remain a sizable market feature even after FTX. Analysts say liquidity, lendin...
Billionaire Activist Investors Just Shake Up Travel Stocks
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...
Exclusive: Startup Aiming Break Nvidia Cloud Hold on AI Data Centers
A London-based startup is funding a hardware-agnostic AI workload platform with $10.25 million in fresh capital, back...
Leading Foreign Sources Shotguns Dominate U.S. Market
A small group of foreign exporters now accounts for the overwhelming majority of shotguns imported into the United St...
Hyperliquid's Token Rises Weekend Amid Market Turbulence
Geopolitical headlines push crypto traders toward nonstop venues. This piece explains why hyperliquid's token rises w...
Another Credit Crash Coming? Signals From a Fragile Market
Many investors worry about a credit squeeze, especially when debt levels rise and lending standards tighten. This gui...
Goldman Sees $100 Oil Coming, ETF Bets 47% Upside Big
Goldman Sachs forecasts a path to $100 oil as geopolitical tensions and supply discipline tighten markets. Meanwhile,...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status